The GLP-1 treatment you want is in a convenient daily pill [USA TODAY]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: USA TODAY
If you've been waiting for a needle-free GLP-1 option , this might be your moment. Weight Watchers Med+ is now offering Novo Nordisk's brand new Wegovy pill , the first FDA-approved oral GLP-1 for weight loss. And for a limited time, eligible patients can get a 30-day supply for just $149 per month for the first four months. This new daily pill delivers weight loss results similar to popular injectable GLP-1s, without the needles, refrigeration, or cleanup. If you've been curious about GLP-1 treatments but hesitant about injections, this drop-and-go pill could be a game-changer. Wegovy pill is Novo Nordisk's newest GLP-1 medication , designed to support weight management alongside diet and exercise. Instead of a weekly shot, you'll take one pill each morning. Can you get similar weight loss results to injectable GLP-1s? In clinical trials, participants taking the oral formulation lost an average of 13.6% of their body weight over 64 weeks. Those on the injectable version lo
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk's Wegovy® Pill Achieves Strong First-Month Uptake, Signaling Expanding Demand for Oral GLP-1s in Obesity [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk A/S: Notice for the Annual General Meeting of Novo Nordisk A/S [Yahoo! Finance]Yahoo! Finance
- Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China [CNBC]CNBC
- What Is HIMS Worth Without GLP-1? Earnings Preview [Seeking Alpha]Seeking Alpha
- Hims & Hers Health to acquire Australia's Eucalyptus for up to $1.15 billion [CNBC]CNBC
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 2/20/26 - Form 6-K
- 2/17/26 - Form 6-K
- 2/11/26 - Form 6-K
- NVO's page on the SEC website